首页> 外文期刊>Technology and health care: official journal of the European Society for Engineering and Medicine >Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia
【24h】

Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia

机译:成本最小化分析在结肠癌和缺铁性贫血患者的术前治疗中,较之于蔗糖铁或口服铁剂,更倾向于静脉使用羧甲基麦芽糖

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Ferric Carboxymaltose (FCM), Iron Sucrose (IS) and Oral Iron (OI) are alternative treatments for preoperative anaemia.
机译:背景:铁羧糖(FCM),蔗糖铁(IS)和口服铁(OI)是术前贫血的替代疗法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号